发明名称 Controlled release hydrocodone formulations
摘要 A solid oral controlled-release dosage form of hydrocodone is disclosed, the dosage form comprising an analgesically effective amount of hydrocodone or a pharmaceutically acceptable salt thereof, and controlled release material.
申请公布号 US9572804(B2) 申请公布日期 2017.02.21
申请号 US201615019106 申请日期 2016.02.09
申请人 Purdue Pharma L.P. 发明人 Oshlack Benjamin;Huang Hua-Pin;Masselink John K.;Tonelli Alfred
分类号 A61K31/485;A61K9/00;A61K9/20;A61K9/14;A61K31/46;A61K31/194 主分类号 A61K31/485
代理机构 Davidson, Davidson and Kappel, LLC 代理人 Davidson, Davidson and Kappel, LLC
主权项 1. A solid oral controlled-release dosage form of hydrocodone, the dosage form comprising a matrix comprising hydrocodone or a pharmaceutically acceptable salt thereof and a cellulose ether, such that the dosage form provides a ratio of a plasma concentration of hydrocodone at the end of a dosing interval to a maximum plasma concentration of hydrocodone during the dosing interval of from 0.55 to 1 and effective pain relief over a period of time of about 12 hours or longer after administration to a human patient, wherein the dosage form is a tablet, and the hydrocodone or pharmaceutically acceptable salt thereof is the only active agent in the dosage form.
地址 Stamford CT US